We utilised them as carriers for IFIH1‐M, and IFIH1‐M‐EVs were administered via tail vein injection at a dose of 1 × 1010 particles/mouse for the treatment of LPS‐induced ARDS. This evidence concerns the gene IFIH1 and acute respiratory distress syndrome.